The defining pathology of the new clinical and histopathologic entity ACTA2-related cerebrovascular disease
© Georgescu et al. 2015
Received: 24 November 2015
Accepted: 24 November 2015
Published: 4 December 2015
Smooth muscle cell contraction is an essential function of arteries and relies on the integrity of the actin-myosin apparatus. The tissue-specific α2-smooth muscle actin, encoded by ACTA2, is predominantly expressed in vascular smooth muscle cells. ACTA2 mutations predispose to development of aortic aneurysms and early onset coronary and cerebrovascular disease. Based on arteriographic findings, a distinct cerebrovascular disease has been proposed for ACTA2 heterozygous patients carrying the R179H mutation.
We present the first integrated analysis of a severely compromised patient with the R179H mutation and define the arterial pathology of ACTA2-related cerebrovascular disease. Histologically, striking morphological abnormalities were present in cerebral arteries of all sizes. Massive intimal smooth muscle cell proliferation, fragmentation of the elastic laminae and medial fibromuscular proliferation characterized large arteries whereas prominent vessel wall thickening, fibrosis and smooth muscle cell proliferation were unique changes in small arteries. The medial fibrosis and smooth muscle cell proliferation explain the characteristic radiologic appearance of “straight arteries” and suggest impaired function of mutant smooth muscle cells. Actin three-dimensional molecular modeling revealed critical positioning of R179 at the interface between the two strands of filamentous actin and destabilization of inter-strand bundling by the R179H mutation, explaining the severe associated phenotype.
In conclusion, these characteristic clinical and pathologic findings confirm ACTA2-related cerebrovascular disease as a new cerebrovascular disorder for which new therapeutic strategies need to be designed.
Smooth muscle cells (SMCs) form the muscle layers of tubular viscera and blood vessels . Their contractile activity, generated by the actin-myosin complex, provides blood vessels and tubular viscera with motility, tonus and compliance. Unlike skeletal muscle fibers, in which the actin-myosin apparatus is organized into sarcomeres, the contractile filaments in SMC crisscross obliquely through the cell forming a lattice-like network . In addition to serving a contractile function, SMCs synthesize extracellular matrix (ECM) components such as collagen, elastin and proteoglycans, similar to fibroblasts .
Actin is the most abundant protein in many cell types. It exists as a 42-kDa globular (G)-actin monomer and, upon poymerization, as a double-stranded helical filamentous (F)-actin structure. Six isoforms of actin encoded by different genes are present in humans, of which two α isoforms are selectively expressed in skeletal and cardiac muscles, and two cytoplasmic isoforms, β and γ, are ubiquitously expressed in muscle and non-muscle cells . Two isoforms of smooth muscle actin (SMA), α2-SMA and γ-SMA, are present in SMCs in various proportions depending on the organ. Whereas γ-SMA is preferentially expressed in viscera, α2-SMA is highly expressed in vascular SMCs. Interestingly, veins but not arteries, express high levels of γ-SMA in addition to α2-SMA . α2-SMA is encoded by ACTA2 on chromosome 10q23.31.
Heterozygous ACTA2 mutations predispose to thoracic aortic aneurysm disease (TAAD) . Mutations can occur de novo and the disease has an autosomal dominant mode of transmission. A subset of ACTA2 mutations also cause early onset coronary artery disease (CAD) and stroke . The stroke phenotype has been previously described as a form of moyamoya disease (MMD) , but recent studies showing lack of susceptibility for MMD on chromosome 10q23 [8, 9] and a different radiologic appearance of the cerebral blood vessels suggest that a distinct cerebrovascular disease is associated with ACTA2 mutations . Among the ACTA2 mutations, the one resulting in the R179H change in α2-SMA confers a particularly severe cerebral arteriopathy that differs from classical MMD [10, 11]. Other ACTA2 mutations predisposing to stroke have been reported, such as those resulting in R258C/H and R39H changes .
In this study, we performed an integrated clinical, radiologic and pathologic analysis of a unique case harboring the R179H mutation, extending and completing previously reported analyses [10, 11]. Structural modeling of R179H and other ACTA2 mutations involved in the stroke syndrome showed a common positioning on the actin inter-strand surface responsible for F-actin double strand bundling, providing a molecular basis for the new ACTA2-related cerebrovascular disease (ARCD) entity.
Material and methods
Autopsy, histology and digital analysis
These studies were performed in compliance with the ethical guidelines of the Helsinki Declaration and approved by the University of Texas Southwestern Medical Center and Parkland Hospital Health Center ethical committees for research on human subjects. The genetic identification, brief clinical history and radiologic appearance of the patient carrying the heterozygous ACTA2 mutation resulting in the R179H change was described in the addendum  and as patient 6 , 4 years before she expired. Her autopsy and that of a gender, race and age-matched control patient succumbing of cirrhosis were performed in accordance to the UT Southwestern/Parkland Hospital regulations. These patients were of normal weight and comparable height and were free of other risk factors for cardiovascular disease, such as smoking, diabetes, hypercholesterolemia, hypertension or obesity. Representative sections were obtained from all the organs, including aorta. Brains were fixed for 2 weeks in formalin and the following cerebral arteries were carefully dissected prior to sectioning: supraclinoid internal carotid arteries (ICAs), middle cerebral arteries (MCAs), anterior cerebral arteries (ACAs), posterior communicating arteries (PComs), posterior cerebral arteries (PCAs), basilar artery, vertebral arteries (VAs), superior cerebellar arteries and posterior inferior cerebellar arteries. Three 2-mm long fragments were obtained when possible for each artery. Paraffin-embedded sections were processed for hematoxylin-eosin (H&E), Masson trichrome and Verhoeff van Gieson elastic stains for all the arteries. Immunohistochemistry (IHC) was performed on selected sections with α-SMA antibody (clone 1A4, pre-diluted, Ventana Medical Systems, Tucson, AZ). Images were acquired at various magnifications with an Aperio Scanscope CS2 whole slide image system (Leica Biosystems, San Diego, CA) and the measurements of thickness or diameter were performed by using ImageScope software, version 220.127.116.1129 on images at 20x magnification. Measurements of large artery intima and media thickness were performed on the H&E sections of the arterial fragment showing the thickest intima, at maximum and mean thickness, respectively. Measurements of the small vessel wall were performed at mean thickness and caution was taken when vessels were not circular. The measurements of small vessel lumen diameter were performed on α-SMA labeled sections and, when the lumen was elliptic rather than circular, the formula (D + d)/2 was used, where D is the long axis and d, the small axis of the ellipse. SMC nuclei were counted in random fields of large artery media, in a range of 130–361 nuclei/field, and normalized to area, by using the analysis tools in Adobe Photoshop CS6, version 13.0 (Adobe Systems Inc., San Jose, CA).
Radiologic imaging and analysis
Cross sectional imaging studies, including computed tomography (CT) and magnetic resonance imaging (MRI) performed as part of routine clinical care and available from the hospital picture archiving and communication system (PACS), were reviewed by a neuroradiologist. Imaging findings were compared to published literature regarding ACTA2 mutations and MMD. Measurements of luminal diameters and cross sectional areas of the main intracranial arteries were performed on source images of a CT angiography study of the patient, as well as of an age and gender matched second normal control different from the autopsy control, by using the Osirix open source DICOM viewer . Multiplanar reformats of isotropic CT data were performed to obtain long and short axis views of the arteries of interest. Linear measurements were obtained for luminal diameter in the mid portion of the vessels on long axis views and region of interest circular measurements were obtained for area measurements in the short axis views.
The various α2-actin mutations were mapped and aligned in the monomeric α1-actin 3D structure (Protein Data Base accession number 1J6Z). The models of wild-type or mutant α2-actin residues were generated by using PyMol (Version 18.104.22.168 Schrodinger, LLC), as previously described .
The characteristic clinical and angiographic features of ARCD
A 31-year-old female was brought unresponsive to the emergency room by her husband. Upon arrival at an outside hospital, the patient was nonverbal, not following commands and without purposeful movements. There was suspicion of seizure activity due to face and finger twitching, and the patient was intubated for airway protection. The patient had a complex prior medical history including multiple previously repaired aneurysms (aortic root, arch and right axillary artery at age 25 years, and thoracoabdominal aorta at age 26 years), surgical closure for a persistent ductus arteriosus in childhood, congenital mydriasis, intestinal malrotation diagnosed at laparotomy at age 2 years, left salpingo-oophorectomy, colecystectomy at age 23, and obstructive and restrictive chronic lung disease. The patient also had a history of left superficial temporal artery encephalodural synangiosis 2 years and 9 months prior, due to diagnosed MMD, associated with body paresthesias and transient weakness. The constellation of vascular abnormalitites that include aortic aneurysms and persistence of patent ductus arteriosus, with involvement of SMCs in other organs leading to congenital absence of the iris, malrotation of the gut and primary pulmonary hypertention was previously described in individuals with ACTA2 mutations resulting in a change at R179 and was classified as multisystemic smooth muscle dysfunction syndrome . The brief clinical and radiologic description of this patient carrying the R179H mutation was included in the addendum of the latter study  and was also mentioned in the table (patient 6) of the study by Munot et al. . However, her brain imaging findings are comprehensively described below, in this study. A brain MRI at the time of admission revealed large left MCA and bilateral ACA infarcts (Fig. 1a, red arrows), with additional evidence of chronic small vessel white matter disease (periventricular hyperintensities; Fig. 1a, yellow arrow) and postsurgical findings related to prior left pterional craniotomy for revascularization. Head CT confirmed a large hypodense area of acute infarction involving the left MCA and bilateral ACA territories. The patient was admitted to the Neurology intensive care unit for supportive care. At arrival, the patient was comatose with Glasgow Coma Score of 7/15. An electroencephalogram revealed no evidence of seizure activity. Suppression of background activities within the left frontocentral region was observed, corresponding to the patient’s ischemic stroke. Follow-up head CTs at one and two days after arrival did not demonstrate evidence of hemorrhagic transformation, but showed progression of ischemic injury in the posterior left MCA territory, worsening edema, mass effect and rightward midline shift. The family deferred surgical decompression according to the patient’s previously stated requests. The patient expired later on the same day and a postmortem examination was requested.
Review of patient’s prior neuroimaging studies demonstrated findings consistent with her history of ACTA2 mutation-related vasculopathy. Importantly, the CT angiography demonstrated an unusual straight course of most of the intracranial arteries and an absence of the characteristic collaterals seen in MMD (Fig. 1b). To examine the capacity of the large cerebral vessels, we performed measurements on CT angiography images of the luminal cross sectional area and diameter (Additional file 1: Figure S1). Both parameters were significantly lower in the ACTA2-mutant patient compared to a normal age- and gender-matched control (Fig. 1c), suggesting chronic hypoperfusion of the brain. Exceptions were noted in the sites of increased compensatory flow, such as for the left ICA that supplied the right ACA territory through the azygos ACA in addition to the normal left ACA territory, and for the posterior communicating arteries, that supplied the main flow to PCAs due to hypoplasia of the P1 segments of the PCAs (Fig. 1d).
Marked abnormalities of intima and media in ACTA2 mutant large-size cerebral arteries
Gross examination of the brain showed mildly increased weight (1300 g) with signs of edema of the left cerebral hemisphere: widening and flattening of the gyri, softening of the parenchyma, left lateral ventricle narrowing with mild midline shift, mild left subfalcine herniation and left uncal herniation (Additional file 1: Figure S2). Colpocephaly-like dilatation of the trigone and occipital horns of the lateral ventricles, was also noted (Additional file 1: Figure S2, red arrow). The microscopic examination of representative sections confirmed the radiological findings of infarct and showed generalized acute neuronal and glial necrosis, mild neutrophilic reaction and endothelial swelling in the left MCA, ACA and right ACA territories (Additional file 1: Figure S3). Occasional acute ischemic neuronal necrosis was also seen in the right basal ganglia and bilateral thalami (not shown), suggesting global ischemia.
Gross examination of the major arteries of the cerebral circulation confirmed the marked narrowing of the lumen of the right supraclinoid ICA, the unilateral azygos configuration of ACAs and the hypoplasia of the P1 segments of the PCAs noted radiographically (Additional file 1: Figure S4). Although these variants in the anterior and posterior parts of the circle of Willis circulation account each for 2–10 % in the general population , the combination of these variants in a single individual most likely reflects a developmental abnormality. A comparative histological analysis was further carried out between the ACTA2 patient’s arteries and those of a gender and age-matched control (Fig. 2). H&E staining revealed marked thickening of the intima in all major arteries of the anterior cerebral circulation and variable intimal thickening of the arteries of the posterior cerebral circulation (Fig. 2a-b). The intimal thickening explains the decreased lumen diameter and area observed angiographically (Fig. 1c) and the propensity to develop thrombosis. Indeed, both the left MCA and right ICA contained organizing thrombi at autopsy (not shown).
A striking splitting between the intima and the media at the level of the internal elastic lamina was observed in the ACTA2 mutant arteries compared to arteries from the age-matched control patient, especially in the anterior circulation (Fig. 2a arrows). A minimal degree of splitting has been described as an artifact and attributed to the postmortem contraction of the media . The excessive splitting present in the ACTA2 mutant arteries is a postmortem artifact as well but suggests additional deregulation of adhesion between intima and media.
The measurement of the average thickness of the media revealed comparable medial thinning in both anterior and posterior cerebral circulations of the ACTA2 mutant (Fig. 2c). Exceptions were noted in the cases of compensatory flow, such as for the left ICA and the two posterior communicating arteries.
IHC for α-SMA showed massive SMC proliferation in the intima and SMC dissection through the split internal elastic lamina (Fig. 3, α-SMA, blue arrow and red bracket, respectively).
Unique ACTA2 mutant phenotype of small-size arteries
Likewise, the walls of the patient’s small intraparenchymal arteries were significantly thicker than those from the control case arteries, whereas veins showed no difference (Fig. 4b, upper graph). The sparing of the veins may reflect the presence of γ-SMA in these vessels . The measurement of the lumen diameter showed a trend towards a smaller lumen in the ACTA2 mutant, although the majority of the small arteries appeared to have lumens comparable to those in the control case. Luminal dimensions of small veins were similar in patient and control sections (Fig. 4b, lower graph). Histological analysis of the arterial walls revealed massive SMC proliferation and marked fibrosis (Fig. 4b, lower panels), similar to that noted in the media of large-size arteries. The marked proliferation of SMCs in the small size arteries appears to be a unique feature of this disease and has not been observed in other cerebral small size vessel diseases .
Systemic manifestations in ARCD: broad involvement of arterial SMCs
To assess and compare the extent of the vascular disease in other regions beside the brain, we examined representative sections of various organs. The aorta showed thinning of the wall formed by the intima and media (Additional file 1: Figure S7, double headed arrow), in contrast to cerebral arteries, for which the exuberant intimal fibromuscular proliferation accounts for increased thickness. The prominent loss and fragmentation of the elastic lamellae (Additional file 1: Figure S7 arrowheads and elastic stain) replaced by disorganized ECM and SMCs explains the decreased resistance to blood pressure and the formation of aneurysms. The small arteries of the aortic vasa vasorum had thickened walls (Additional file 1: Figure S7, arrows), similar to the small arteries in the brain. Similar histopathologic findings of the aorta have been previously described in patients with the R179H as well as other ACTA2 mutations, including that resulting in the R258H change [6, 12].
The large size muscular arteries in various organs, including those from the kidney, liver and branches of the aorta, showed intimal fibromuscular proliferation, although this change was not as extensive as that seen in the large size cerebral arteries of the anterior circulation (Additional file 1: Figure S8A, D). The small size arteries in the connective tissue and parenchyma of various organs had thicker walls, similarly to those observed in the brain, indicating that this is a generalized defect induced by the ACTA2 mutation (Additional file 1: Figure S8A-D). The medial thickening of the myocardial arteries (Additional file 1: Figure S8C) is similar to the one previously described for the subset of ACTA2 mutations predisposing to CAD . Although not as dramatic as the ischemic changes noted in the brain, evidence of ischemic organ damage was seen in the heart, manifested by areas of fibrosis and cardiomyocyte hypertrophy (Additional file 1: Figure S8C), and in the kidney, with areas of transcortical glomerulosclerosis along the interlobular artery territory. Interestingly, as previously reported , architectural abnormalities that could not be clearly related to a vascular dysfunction – specifically panacinar emphysema – were present.
R179H maps to the interstrand F-actin surface and disrupts F-actin bundling
Both R179 and R258 pathogenic mutations have been described in α2-SMA and γ2-SMA, predisposing for TAAD/stroke and megacystis-microcolon-intestinal hypoperistalsis syndrome, respectively . Remarkably, the residue R179 (R177 in α1-actin) is the site of ADP-ribosylation by Clostridium botulinum, perfringens and difficile C2, iota and transferase CDT toxins, respectively . ADP-ribosylation at this site results in steric hindrance of actin monomer interactions and blockage of polymerization. Mutagenesis of R179 to D in β-actin has been shown to significantly lower polymerization rate and polymer viscosity , suggesting a critical role in actin polymerization. While we modeled the structural effect of the R179H mutation for the first time in this report, the role of the R258H mutation that alters the same inter-strand interface as R179H (Fig. 6a-b) has been extensively studied  and R258H mutagenesis has been shown to cause F-actin polymerization defects [23, 24].
Cerebrovascular disease is a major health problem in developed countries. An understanding of the heterogeneous nature of the abnormalities manifesting clinically as cerebrovascular disease is paramount for developing disease-specific therapies. This report represents the first comprehensive histopathologic analysis of severe cerebrovascular disease resulting from an ACTA2 mutation (ARCD), expanding our knowledge of the pathological spectrum of cerebrovascular disease. ARCD is a systemic disease that affects arteries of all sizes. The striking histopathologic changes of intima and media fibromuscular proliferation of the arteries in the anterior cerebral circulation underlie the characteristic “straight arteries” angiographic sign. While the fibromuscular proliferation of the intima noted in this patient is also a feature of atherosclerosis and MMD [25–27] several aspects distinguish the changes seen in this case from either atherosclerosis or MMD. Macrophage accumulation and cholesterol-rich plaques characteristic of atherosclerosis were not observed. Several differences with MMD were noted as well, including decreased folding of the internal elastic lamina in cross sections as opposed to more complex folding of the internal elastic lamina sometimes seen in MMD . Additionally, the medial changes evident in this case - fibrosis and SMC proliferation - differ from the attenuation of the media in MMD [25, 26]. Perhaps most significantly, the compensatory small vascular collaterals characteristic of MMD were not a feature of this case, and it is possible that the altered composition of the arterial walls in ACRD may play a role in this. In MMD, the collateral vessels and most likely the revascularization following encephalodural synangiosis develop as a response to ischemia and release of angiogenic growth factors, such as vascular endothelial growth factor and others . Although the same compensatory response to ischemia is probably elicited in ARCD, the growth factors produced in the ischemic tissue may not diffuse properly to the endothelial cells through the thick vasculature. Alternatively, a structural deficiency of the vessels in ARCD could interfere with the sprouting of the collateral vascular channels seen in MMD. In this respect, remodeling of the ECM and maintenance of a balance between angiogenic and anti-angiogenic factors, which are in part secreted by SMCs, is necessary for efficient angiogenensis . As the ECM is clearly deregulated in ARCD arteries, most likely as a direct consequence of impaired secretion by mutant SMCs, future work to delineate these possibilities might have therapeutic implications for potential revascularization.
ARCD diffusely involved small arteries and showed histopathologic changes of fibrosis, and SMC proliferation, leading to increased wall thickness that reached in some areas 4-fold higher values than the control. These small vessel changes are unique among hereditary small vessel arteriopathies that, in contrast to ARCD, are characterized by degeneration of SMCs [16, 29]. This characteristic SMC proliferation was present systemically in the small vessels of various organs - lymph node medulla, liver, lung, heart, submucosa and serosa of esophagus, stomach and uterus - and in fibroadipose tissue but not in the sampled abdominal skin. As previously reported, the vasa vasorum in the adventitia had also increased wall thickness . As these patients frequently undergo multiple surgeries, this disease may be suspected when small vessels with SMC proliferation are detected.
The generalized arteriopathy of ARCD induced secondary organ changes, the most prominent and life threatening being in the brain. These were manifested by both acute ischemic change, such as stroke, and chronic ischemic change in the form of leukoencephalopathy and neuronal loss. The MRI T2-weighted hyperintensities in the periventricular white matter (leukoaraiosis) have been previously observed in ACTA2 patients with R179 mutations [10, 12, 30–32] but the histopathologic basis has not been clearly defined. We found areas of rarefaction containing axonal swellings at these sites, similar to lesions described in hereditary diffuse leukoencephalopathy with axonal spheroids and sometimes also seen in CADASIL [16, 33]. Moreover, the colpocephaly, a developmental abnormality that has been linked to white matter underdevelopment of various causes , has been also reported later in life in this patient and in a second patient carrying the R179H mutation . This colpocephaly-like ventricular dilatation is suggestive of progressive chronic ischemic damage of the periventricular white matter in ARCD patients. Interestingly, the severe neuronal loss in the hippocampus, predominantly in the CA1 area, is most likely attributable to chronic ischemia as well. This finding is similar to the changes described in hippocampal sclerosis, which are considered to be a consequence of age-related angiopathy in some cases .
ARCD has both common and distinctive features from other vascular syndromes, the former stemming most likely from the interplay of secondary compensatory mechanisms following arterial injury. To integrate ARCD into the broader field of vascular disease, we modeled its pathogenesis starting with its characteristic structural alteration, the R179H α2-SMA mutation (Fig. 6e). Based on our structure modeling, the common mechanistic denominator for the R179H and R258H mutations described in ARCD  is most likely the destabilization of the F-actin inter-strand interface. Predictably, the severity of inter-strand bundling disruption depends on the mutant:wild-type ratio protein concentration and on the relative position of the mutant protein incorporated into the actin filament (Fig. 6e). These events may have secondary allosteric effects on the association of actin with actin-binding proteins, such as formin, which is required for nucleation and elongation of F-actin, thus causing severe disruption of F-actin polymerization . Because of its critical positioning, the mutation of R179 might cause a more severe disruption of actin polymerization than other mutations, which may explain the more severe and generalized phenotype reported for R179 mutations . How the alterations of actin polymerization translate into the morphogenetic abnormalities observed in the cases of ARCD is not known. It has been shown that only a small amount of actin in SMCs undergoes active polymerization in a submembranous network that serves to strengthen the membrane for the transmission of force generated by the contractile apparatus to the extracellular matrix . An abnormal submembranous actin polymerization would give rise to decreased SMC membrane rigidity and thus decreased contractility (Fig. 6e). Surprisingly, the ACTA2 knock-out mice share with the human mutant ACTA2 patients only the blood pressure dysregulation due to contractility impairment. Otherwise, these mice are viable and do not have morphological cardiovascular defects, most likely due to compensatory expression of skeletal muscle actin in their vessels . This suggests a dominant-negative effect of the mutant α2-SMA on vasculature morphogenesis with alteration of other SMC functions than contractility. Indeed, the fibrosis of media and accumulation of abundant ground substance and disorganized elastin in the intima of the ARCD arteries suggests that the secretory function of SMCs is deregulated. Whether SMCs with R179H mutant α2-SMA secrete abnormal ECM directly or as a consequence of arterial damage due to inefficient contractility is not clear. Due to similarities with other TAADs and cerebral vasculopathies with abnormal ECM [29, 38], a compensatory secretion of abnormal ECM is probably taking place (Fig. 6e). Both elastin knockout mice and humans with supravalvular aortic stenosis characterized by loss-of-function mutations on one elastin allele have uncontrolled SMC proliferation in the intima leading to arterial stenosis and death [3, 39]. It has been shown that the intimal SMC proliferation results from decreased deposition of insoluble elastin and, conversely, that addition of insoluble elastin inhibits SMC proliferation . Strikingly, massive intimal SMC proliferation was present in most of the large size cerebral arteries in ARCD, most likely due to defective elastin deposition . Although this loop may be involved in the characteristic proliferation of the SMC population from the media of large arteries or wall of small arteries, the hypothesis of an intrinsic hyperproliferative phenotype of mutant ACTA2 SMCs remains to be explored (Fig. 6e). Notably, SMCs from ACTA2 knock-out mice proliferate and migrate more rapidly than control SMCs .
In conclusion, this study presents the first comprehensive analysis of cerebrovascular changes in a patient with ARCD and offers morphological explanations for many of the clinical findings. The cues that trigger the global artery morphogenetic defects are yet to be found. These may not only explain why the correction of the vascular flow by arterial bypass, a procedure successfully used in MMD, usually fails in ARCD patients, but also unravel new treatment options directed to target the arterial obstructive pathology in ARCD.
The authors thank Gilbert Cote, Chang Foong and Pam Curry for help with graphing and slide scanning, Kathryn Bartush and Jeff Harris for excellent technical assistance and Ellen Regalado for logistical assistance.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Junqueira LC, Carneiro J (2005) Basic Histology. 11th edn. McGraw-Hill Companies, Inc.Google Scholar
- Yamin R, Morgan KG. Deciphering actin cytoskeletal function in the contractile vascular smooth muscle cell. J Physiol. 2012;590:4145–54.PubMed CentralView ArticlePubMedGoogle Scholar
- Lannoy M, Slove S, Jacob MP. The function of elastic fibers in the arteries: beyond elasticity. Pathol Biol (Paris). 2014;62:79–83.View ArticleGoogle Scholar
- Tondeleir D, Vandamme D, Vandekerckhove J, Ampe C, Lambrechts A. Actin isoform expression patterns during mammalian development and in pathology: insights from mouse models. Cell Motil Cytoskeleton. 2009;66:798–815.View ArticlePubMedGoogle Scholar
- Arnoldi R, Hiltbrunner A, Dugina V, Tille JC, Chaponnier C. Smooth muscle actin isoforms: a tug of war between contraction and compliance. Eur J Cell Biol. 2013;92:187–200.View ArticlePubMedGoogle Scholar
- Guo DC, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, Avidan N, et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet. 2007;39:1488–93.View ArticlePubMedGoogle Scholar
- Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet. 2009;84:617–27.PubMed CentralView ArticlePubMedGoogle Scholar
- Guey S, Tournier-Lasserve E, Herve D, Kossorotoff M. Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet. 2015;8:49–68.PubMed CentralPubMedGoogle Scholar
- Shimojima K, Yamamoto T. ACTA2 is not a major disease-causing gene for moyamoya disease. J Hum Genet. 2009;54:687–8.View ArticlePubMedGoogle Scholar
- Munot P, Saunders DE, Milewicz DM, Regalado ES, Ostergaard JR, Braun KP, et al. A novel distinctive cerebrovascular phenotype is associated with heterozygous Arg179 ACTA2 mutations. Brain. 2012;135:2506–14.PubMed CentralView ArticlePubMedGoogle Scholar
- Amans MR, Stout C, Fox C, Narvid J, Hetts SW, Cooke DL, et al. Cerebral arteriopathy associated with Arg179His ACTA2 mutation. J Neurointerv Surg. 2014;6:e46.View ArticlePubMedGoogle Scholar
- Milewicz DM, Ostergaard JR, Ala-Kokko LM, Khan N, Grange DK, Mendoza-Londono R, et al. De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction. Am J Med Genet A. 2010;152A:2437–43.PubMed CentralView ArticlePubMedGoogle Scholar
- Rosset A, Spadola L, Ratib O. OsiriX: an open-source software for navigating in multidimensional DICOM images. J Digit Imaging. 2004;17:205–16.PubMed CentralView ArticlePubMedGoogle Scholar
- Morales FC, Takahashi Y, Momin S, Adams H, Chen X, Georgescu MM. NHERF1/EBP50 Head-to-Tail Intramolecular Interaction Masks Association with PDZ Domain Ligands. Mol Cell Biol. 2007;27:2527–37.PubMed CentralView ArticlePubMedGoogle Scholar
- Chen HW, Yen PS, Lee CC, Chen CC, Chang PY, Lee SK, et al. Magnetic resonance angiographic evaluation of circle of Willis in general population: A morphologic study in 507 cases. Chin J Radiol. 2004;29:223–9.Google Scholar
- Craggs LJ, Yamamoto Y, Deramecourt V, Kalaria RN. Microvascular pathology and morphometrics of sporadic and hereditary small vessel diseases of the brain. Brain Pathol. 2014;24:495–509.PubMed CentralView ArticlePubMedGoogle Scholar
- Fujii T, Iwane AH, Yanagida T, Namba K. Direct visualization of secondary structures of F-actin by electron cryomicroscopy. Nature. 2010;467:724–8.View ArticlePubMedGoogle Scholar
- von der Ecken J, Muller M, Lehman W, Manstein DJ, Penczek PA, Raunser S. Structure of the F-actin--tropomyosin complex. Nature. 2015;519:114–7.View ArticlePubMedGoogle Scholar
- Wangler MF, Gonzaga-Jauregui C, Gambin T, Penney S, Moss T, Chopra A, et al. Heterozygous de novo and inherited mutations in the smooth muscle actin (ACTG2) gene underlie megacystis-microcolon-intestinal hypoperistalsis syndrome. PLoS Genet. 2014;10:e1004258.PubMed CentralView ArticlePubMedGoogle Scholar
- Aktories K, Schwan C, Papatheodorou P, Lang AE. Bidirectional attack on the actin cytoskeleton. Bacterial protein toxins causing polymerization or depolymerization of actin. Toxicon. 2012;60:572–81.View ArticlePubMedGoogle Scholar
- Schuler H, Nyakern M, Schutt CE, Lindberg U, Karlsson R. Mutational analysis of arginine 177 in the nucleotide binding site of beta-actin. Eur J Biochem. 2000;267:4054–62.View ArticlePubMedGoogle Scholar
- Rubenstein PA, Wen KK. Insights into the effects of disease-causing mutations in human actins. Cytoskeleton (Hoboken). 2014;71:211–29.View ArticleGoogle Scholar
- Lu H, Fagnant PM, Bookwalter CS, Joel P, Trybus KM. Vascular disease-causing mutation R258C in ACTA2 disrupts actin dynamics and interaction with myosin. Proc Natl Acad Sci U S A. 2015;112:E4168–4177.View ArticlePubMedGoogle Scholar
- Malloy LE, Wen KK, Pierick AR, Wedemeyer EW, Bergeron SE, Vanderpool ND, et al. Thoracic aortic aneurysm (TAAD)-causing mutation in actin affects formin regulation of polymerization. J Biol Chem. 2012;287:28398–408.PubMed CentralView ArticlePubMedGoogle Scholar
- Lummus S, Breeze R, Lucia MS, Kleinschmidt-DeMasters BK. Histopathologic features of intracranial vascular involvement in fibromuscular dysplasia, ehlers-danlos type IV, and neurofibromatosis I. J Neuropathol Exp Neurol. 2014;73:916–32.View ArticlePubMedGoogle Scholar
- Takekawa Y, Umezawa T, Ueno Y, Sawada T, Kobayashi M. Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease. Neuropathology. 2004;24:236–42.View ArticlePubMedGoogle Scholar
- Weinberg DG, Arnaout OM, Rahme RJ, Aoun SG, Batjer HH, Bendok BR. Moyamoya disease: a review of histopathology, biochemistry, and genetics. Neurosurg Focus. 2011;30:E20.View ArticlePubMedGoogle Scholar
- Wietecha MS, Cerny WL, DiPietro LA. Mechanisms of vessel regression: toward an understanding of the resolution of angiogenesis. Curr Top Microbiol Immunol. 2013;367:3–32.PubMedGoogle Scholar
- Tikka S, Baumann M, Siitonen M, Pasanen P, Poyhonen M, Myllykangas L, et al. CADASIL and CARASIL. Brain Pathol. 2014;24:525–44.View ArticlePubMedGoogle Scholar
- Meuwissen ME, Lequin MH, Bindels-de Heus K, Bruggenwirth HT, Knapen MF, Dalinghaus M, et al. ACTA2 mutation with childhood cardiovascular, autonomic and brain anomalies and severe outcome. Am J Med Genet A. 2013;161A:1376–80.View ArticlePubMedGoogle Scholar
- Moosa AN, Traboulsi EI, Reid J, Prieto L, Moran R, Friedman NR. Neonatal stroke and progressive leukoencephalopathy in a child with an ACTA2 mutation. J Child Neurol. 2013;28:531–4.View ArticlePubMedGoogle Scholar
- Richer J, Milewicz DM, Gow R, de Nanassy J, Maharajh G, Miller E, et al. R179H mutation in ACTA2 expanding the phenotype to include prune-belly sequence and skin manifestations. Am J Med Genet A. 2012;158A:664–8.View ArticlePubMedGoogle Scholar
- Nicholson AM, Baker MC, Finch NA, Rutherford NJ, Wider C, Graff-Radford NR, et al. CSF1R mutations link POLD and HDLS as a single disease entity. Neurology. 2013;80:1033–40.PubMed CentralView ArticlePubMedGoogle Scholar
- Puvabanditsin S, Garrow E, Ostrerov Y, Trucanu D, Ilic M, Cholenkeril JV. Colpocephaly: a case report. Am J Perinatol. 2006;23:295–7.View ArticlePubMedGoogle Scholar
- Neltner JH, Abner EL, Baker S, Schmitt FA, Kryscio RJ, Jicha GA, et al. Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain. 2013;137:255–67.PubMed CentralView ArticlePubMedGoogle Scholar
- Gunst SJ, Zhang W. Actin cytoskeletal dynamics in smooth muscle: a new paradigm for the regulation of smooth muscle contraction. Am J Physiol Cell Physiol. 2008;295:C576–587.PubMed CentralView ArticlePubMedGoogle Scholar
- Schildmeyer LA, Braun R, Taffet G, Debiasi M, Burns AE, Bradley A, et al. Impaired vascular contractility and blood pressure homeostasis in the smooth muscle alpha-actin null mouse. FASEB J. 2000;14:2213–20.View ArticlePubMedGoogle Scholar
- Lindsay ME, Dietz HC. The genetic basis of aortic aneurysm. Cold Spring Harb Perspect Med. 2014;4:a015909.View ArticlePubMedGoogle Scholar
- Urban Z, Riazi S, Seidl TL, Katahira J, Smoot LB, Chitayat D, et al. Connection between elastin haploinsufficiency and increased cell proliferation in patients with supravalvular aortic stenosis and Williams-Beuren syndrome. Am J Hum Genet. 2002;71:30–44.PubMed CentralView ArticlePubMedGoogle Scholar
- Papke CL, Cao J, Kwartler CS, Villamizar C, Byanova KL, Lim SM, et al. Smooth muscle hyperplasia due to loss of smooth muscle alpha-actin is driven by activation of focal adhesion kinase, altered p53 localization and increased levels of platelet-derived growth factor receptor-beta. Hum Mol Genet. 2013;22:3123–37.PubMed CentralView ArticlePubMedGoogle Scholar